Literature DB >> 27838800

Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Caroline Goehringer1, Christian Sutter2, Matthias Kloor3, Johannes Gebert3, Emily P Slater4, Monika Keller5, Irmgard Treiber6, Petra Ganschow7, Martina Kadmon8, Ute Moog2.   

Abstract

We report on three brothers affected by pancreatic tumors, all due to different causes, including mutations associated with two different cancer predisposition syndromes in the same individual. In the index patient a germline mutation both in the APC and BRCA2 gene was identified while one affected brother showed the BRCA2 mutation only and another brother is supposed to have developed pancreatic cancer due to multiple non-genetic risk factors. We outline the impact of a double germline mutation in two tumor predisposition genes in one individual and proven heterogeneity of multiple cases of pancreatic tumors in one family. With the growing implementation of next generation sequence based panel testing for multiple genes involved in tumor predisposition syndromes, relevant variants in two (or more) genes will be found more frequently. This family illustrates the importance of family studies, especially when using gene panel tests.

Entities:  

Keywords:  APC gene; BRCA2 gene; Double germline mutation; Familial adenomatous polyposis; Familial pancreatic cancer; Hereditary breast and ovarian cancer syndrome; Hereditary pancreatic cancer; Pancreatic cancer; Tumor disposition syndrome

Mesh:

Substances:

Year:  2017        PMID: 27838800     DOI: 10.1007/s10689-016-9952-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  45 in total

Review 1.  Hereditary factors in pancreatic cancer.

Authors:  Henry T Lynch; Randall E Brand; Jane F Lynch; Ramon M Fusaro; Scott E Kern
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

2.  The silent mutation nucleotide 744 G --> A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping.

Authors:  Thomas V O Hansen; Ane Y Steffensen; Lars Jønson; Mette K Andersen; Bent Ejlertsen; Finn C Nielsen
Journal:  Breast Cancer Res Treat       Date:  2009-03-08       Impact factor: 4.872

Review 3.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

4.  Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.

Authors:  Chunling Hu; Steven N Hart; William R Bamlet; Raymond M Moore; Kannabiran Nandakumar; Bruce W Eckloff; Yean K Lee; Gloria M Petersen; Robert R McWilliams; Fergus J Couch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-19       Impact factor: 4.254

5.  PALB2 mutations in European familial pancreatic cancer families.

Authors:  E P Slater; P Langer; E Niemczyk; K Strauch; J Butler; N Habbe; J P Neoptolemos; W Greenhalf; D K Bartsch
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

6.  Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors:  Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Authors:  Kathleen M Murphy; Kieran A Brune; Constance Griffin; Jennifer E Sollenberger; Gloria M Petersen; Ravi Bansal; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

8.  Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors.

Authors:  M Pedroni; C Di Gregorio; L Cortesi; L Reggiani Bonetti; G Magnani; M L Simone; V Medici; C Priore Oliva; M Marino; M Ponz de Leon
Journal:  Tech Coloproctol       Date:  2013-05-22       Impact factor: 3.781

9.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

10.  Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.

Authors:  Femke A de Snoo; D Timothy Bishop; Wilma Bergman; Inge van Leeuwen; Clasine van der Drift; Frans A van Nieuwpoort; Coby J Out-Luiting; Hans F Vasen; Jeanet A C ter Huurne; Rune R Frants; Rein Willemze; Martijn H Breuning; Nelleke A Gruis
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

View more
  3 in total

1.  Five Italian Families with Two Mutations in BRCA Genes.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Giovanna D'Elia; Marianna Resse; Amelia Casamassimi; Pellegrino Biagio Minucci; Concetta Dello Ioio; Michele Cioffi; Anna Maria Molinari
Journal:  Genes (Basel)       Date:  2020-12-03       Impact factor: 4.096

2.  Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.

Authors:  Maria Teresa Vietri; Giovanna D'Elia; Gemma Caliendo; Luisa Albanese; Giuseppe Signoriello; Claudio Napoli; Anna Maria Molinari
Journal:  Genes (Basel)       Date:  2022-02-09       Impact factor: 4.096

3.  Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma.

Authors:  Jennifer M Cole; Kaitlyn Simmons; Jenifer R Prosperi
Journal:  Cells       Date:  2019-09-14       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.